Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for IM Cannabis Corp. (IMCC : NSDQ)

• Company Description    IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel. Number of Employees: 55

• Price / Volume Information    Yesterday's Closing Price: $1.97 Daily Weekly Monthly 20 Day Moving Average: 70,186 shares Shares Outstanding: 5.25 (millions) Market Capitalization: $10.34 (millions) Beta: 2.19 52 Week High: $7.12 52 Week Low: $1.29 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -25.94% -27.24% 12 Week -33.45% -39.55% Year To Date -15.49% -23.01%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3606 - 833 SEYMOUR STREET - VANCOUVER,A1 V6B 0G4 CAN ph: 972-54-433-1111 fax: - maya.l@imcannabis.com http://www.imcannabis.com

• General Corporate Information    Officers Oren Shuster - Chief Executive Officer and Chairman Uri Birenberg - Chief Financial Officer Moti Marcus - Director Einat Zakariya - Director Brian Schinderle - Director Peer Information IM Cannabis Corp. (BJCT) IM Cannabis Corp. (CADMQ) IM Cannabis Corp. (APNO) IM Cannabis Corp. (UPDC) IM Cannabis Corp. (IMTIQ) IM Cannabis Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 44969Q406 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 5.25 Most Recent Split Date: 7.00 (0.17:1) Beta: 2.19 Market Capitalization: $10.34 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.71 Price/Cash Flow: - Price / Sales: 0.27 EPS Growth vs. Year Ago Period: 58.82% vs. Previous Quarter: -216.67% Sales Growth vs. Year Ago Period: -14.89% vs. Previous Quarter: 5.39% ROE 06/30/25 - -59.80 03/31/25 - -122.96 12/31/24 - -151.19 ROA 06/30/25 - -5.15 03/31/25 - -11.69 12/31/24 - -19.43 Current Ratio 06/30/25 - 0.72 03/31/25 - 0.72 12/31/24 - 0.67 Quick Ratio 06/30/25 - 0.62 03/31/25 - 0.59 12/31/24 - 0.58 Operating Margin 06/30/25 - -4.19 03/31/25 - -9.10 12/31/24 - -14.93 Net Margin 06/30/25 - -4.19 03/31/25 - -9.10 12/31/24 - -20.10 Pre-Tax Margin 06/30/25 - -4.55 03/31/25 - -11.97 12/31/24 - -23.68 Book Value 06/30/25 - 0.73 03/31/25 - 0.99 12/31/24 - 1.03 Inventory Turnover 06/30/25 - 9.55 03/31/25 - 9.49 12/31/24 - 8.56 Debt-to-Equity 06/30/25 - 0.32 03/31/25 - 0.10 12/31/24 - 0.15 Debt-to-Capital 06/30/25 - 24.21 03/31/25 - 9.02 12/31/24 - 12.90

Powered by Zacks Investment Research ©